Durham, NC - Stem cell company Aldagen Inc. has refiled to go public and has raised $7.3 million of a targeted $10 million debt and warrants raise, according to SEC filings. The company hopes to raise as much as $80.5 million selling stock on Nasdaq under the symbol “ALDH.” (more…)

Duluth, GA - Halscion Inc., a biotech company developing a device to reduce the appearance of scares from surgical wounds, has raised $6 million of a targeted $35.5 million round, according to a regulatory filing. (more…)

Durham, NC - Metabolon Inc., a company selling biomarker discovery and analysis services, has closed on an additional $6 million Series C funding, bringing its C round total to $12.3 million. New investors were Syngenta Ventures, the corporate venture capital subsidiary of Syngenta, and Fletcher Spaght Ventures. (more…)

Miramar, FL - Altor Bioscience, a company developing treatments that target drugs directly at a tumor or virus, has closed on $1.2 million as part of a series of C1 round investments. Sanderling Ventures, which led the company’s B round, and private investors participated. (more…)

Atlanta, GA - Inhibitex Inc. (Nasdaq: INHX) has entered into definitive purchase agreements with institutional investors for the sale of approximately $23 million of its common stock, and warrants to purchase common stock, in a private placement. (more…)

Blacksburg, VA - Keraderm Corp., a company starting clinical trials of its technology to use phototherapy to treat nail and skin infections, has raised a $2.5 million first round from NewVa Capital Partners. (more…)

Jupiter, FL - Envoy Therapeutics, a recently founded company focused on new treatments for neuological and psychiatric diseases, has raised an $8 million first round led by 5AM Ventures with Takea Research Investment and Roche Venture Fund participating. (more…)

Atlanta, GA - Southeast BIO (SEBIO) announces the selection of the best life sciences deals in the Southeast, as determined by a Selection Committee comprised of regional and national venture capitalists. These companies, both early- and later-stage, will participate in the upcoming SEBIO Investor Forum being held on December 3-4, 2009 at the Charleston Place Hotel in Charleston, South Carolina. (more…)

Research Triangle Park, NC - TransEnterix Inc. has secured $55 million in a second round of institutional financing led by Aisling Capital with new investors Intersouth Partners and Quaker BioVentures and existing investors SV Life Science Advisers, Synergy Life Science Partners and Parish Capital Advisors participating. The company says the funding paves the way for it to make and market its “revolutionary” laparoscopic surgical platform. (more…)

Knoxville, TN - ABT Molecular Imaging, a medical imaging company developing a production platform to make molecular imaging drugs used in PET scans more conveniently and inexpensively, has secured a $9 million round of financing. Durham, NC-based Intersouth Partners led the Series A financing, with company founders participating. (more…)